rediff.com
e.g. Tata motors, Reliance MF, 500570
Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Sources of funds
Owner's fund
Equity share capital 45.31 45.31 45.56 0.25
Share application money - - - -
Preference share capital - - - -
Reserves & surplus 1,576.15 1,393.27 1,238.71 -0.02
Loan funds
Secured loans 250.80 206.71 324.62 -
Unsecured loans - - - -
Total 1,872.26 1,645.29 1,608.90 0.23
Uses of funds
Fixed assets
Gross block 1,426.50 1,265.92 1,062.91 -
Less : revaluation reserve - - - -
Less : accumulated depreciation 473.17 417.52 361.80 -
Net block 953.33 848.40 701.12 -
Capital work-in-progress 136.92 101.90 187.37 -
Investments 61.66 42.67 39.87 -
Net current assets
Current assets, loans & advances 1,145.00 970.30 898.48 0.25
Less : current liabilities & provisions 424.65 317.98 217.93 0.02
Total net current assets 720.35 652.32 680.55 0.23
Miscellaneous expenses not written - - - -
Total 1,872.26 1,645.29 1,608.90 0.23
Notes:
Book value of unquoted investments 30.32 29.16 26.35 -
Market value of quoted investments - - - -
Contingent liabilities 29.03 20.86 19.40 -
Number of equity sharesoutstanding (Lacs) 906.26 906.26 908.76 2.50
Close
Add Aarti Pharmalabs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aarti Pharmalabs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close